None of this stacks with NovoCare, so pick one path
Quick Facts Brand Name: Ozempic Drug Used For: Type-2 Diabetes and off-label weight loss Active Ingredient: Semaglutide Manufacturers With Lawsuits: Novo Nordisk Potential Severe Complications: Stomach paralysis, bowel obstruction, blood clots, vision loss Lawsuit Type: Multidistrict litigation Lawsuit Status: Active Ozempic Lawsuit July 2026 Update Individuals are filing Ozempic lawsuits against Novo Nordisk, alleging a range of injuries, including varied gastrointestinal injuries, vision loss, and pulmonary embolisms
Any app that sets you under 1000 calories/day and does not require any bloodwork to ensure youre healthy to diet is dangerous, says James J
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People With Obesity or Overweight: A Systematic Review
Regulatory action has been directed at the pharmacies and telehealth platforms that compounded and distributed the products